Navigation Links
Poniard Pharmaceuticals Announces Clinical Data from Picoplatin,Phase 2 Small Cell Lung Cancer Trial To Be Presented at American,Society of Clinical Oncology Annual Meeting

-- Data from Picoplatin Phase 1 Colorectal and Prostate Cancer Trials To Be Published in 2007 ASCO Proceedings --

SOUTH SAN FRANCISCO, Calif., May 23, 2007 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. , a biopharmaceutical company focused on oncology, today announced that data from a Phase 2 trial of picoplatin, the Company's lead product candidate, in patients with small cell lung cancer (SCLC) will be presented in a poster session at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) at McCormick Place in Chicago. Details are as follows:

    -- Abstract #7722, Poster #EE3

       A Phase 2 study of picoplatin as second-line therapy for patients with

       small cell lung cancer who have resistant or refractory disease or have

       relapsed within 180 days of completing first-line, platinum-containing

       chemotherapy.

       Bentzion D, Lipatov O, Poliakov I, MacKintosh R, Eckardt J, Breitz H.

       General Poster Session: Sunday, June 3, 8:00 a.m. to 12 p.m. Central

       time S Hall A2

In addition, two picoplatin abstracts have been selected for publication in the 2007 ASCO Proceedings and will be available online through http://asco.org. These abstracts include safety data from an ongoing Phase 1/2 study of picoplatin for the potential front-line treatment of colorectal cancer and from an ongoing Phase 1/2 study of picoplatin and docetaxel (Taxotere(R)) in chemotherapy-naive patients with metastatic hormone-refractory prostate cancer. Details are as follows:

    -- Abstract #14510

       Phase 1 study of picoplatin in combination with 5-fluorouracil and

       leucovorin as initial therapy in subjects with metastatic colorectal

       cancer.

       Gladkov Jr O, Manikhas G, Biakhov M, Tjulandin S, Karlin D.


    -- Abstract #15546

       Phase 1 study of picoplatin and doc
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:11/24/2014)... 24, 2014  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ... corporate overview and update at the Piper Jaffray 26 th ... 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time), at The ... . A live audio webcast of the presentation ... website at www.arenapharm.com . A replay of the presentation ...
(Date:11/24/2014)... , Nov. 24, 2014 Luoxis ... (NYSE MKT: AMPE), today announced the presentation of ... Diagnostic System as a broadly applicable and robust ... in the body in response to injury, illness, ... performed in collaboration with Luoxis, academic and pharmaceutical ...
(Date:11/24/2014)... CHICAGO , Nov. 24, 2014 The ... will host an investor conference call to discuss its ... ended September 30, 2014 on Tuesday, December 2, 2014 ... expects to report its operating results earlier the same ... participate in the conference call by dialing 1-877-374-8416 (international ...
Breaking Medicine Technology:Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 2Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 3Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 4Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 5The Female Health Company To Report FY2014 Operating Results on Tuesday, December 2, 2014 2
(Date:11/26/2014)... Sonoran Vein and Endovascular nurse, ... Distinguished Preceptorship Award from The American Association ... the advancement of nurse practitioners. The Distinguished Preceptorship ... had made a significant contribution toward increasing the ... of Nurse Practitioners (AANP) is the largest full-service ...
(Date:11/26/2014)... Nov. 25, 2014 (HealthDay News) -- Vultures have developed ... they ingest when eating dead animals, researchers report. ... found on the faces and in the guts of ... States. On average, the faces of the vultures had ... 76 in their guts, the study found. The ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Exposure to peanut protein ... allergy in infants with the skin condition eczema, a ... children in the United States are allergic to peanuts. ... food allergies, particularly peanut allergy, the researchers noted. ... to 15 months. The researchers examined the amount of ...
(Date:11/26/2014)... TUESDAY, Nov. 25, 2014 (HealthDay News) -- Parents need ... from sports concussions, an expert warns. Parents must ... and undergo standard, Dr. David Dodick, chair of the ... the Mayo Clinic College of Medicine in Scottsdale, Ariz. ... news release. Any coach involved with teens ...
(Date:11/24/2014)... CA (PRWEB) November 24, 2014 The ... its readers reviews of affordable skin care products, recently ... casual blog offers readers a wide variety of articles, ... as well as organic skincare alternatives. , According to ... Care Journal’s main content includes thoroughly researched reviews, tips ...
Breaking Medicine News(10 mins):Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2Health News:Parents Need to Take Lead on Teen Concussion Prevention 2Health News:Skin Care Advice Blog The Healthy Skin Care Journal Now Accessible to the Public 2
... ... for women experiencing perimenopause and menopause that offers many of the benefits of ... ingredients that relieves menopause symptoms and improves bone density. The ingredients in Estrofil ... , ...
... ... single port technique for gynaecological procedures, raising the bar for minimally invasive surgery. ... Singapore (Vocus) May ... minimally invasive surgery to new heights with the introduction of a specially designed ...
... that predicts the likelihood of relapse in patients with ... has been discovered. Researchers publishing in the open access ... pattern in five genes that has the potential to ... more aggressive treatment when first diagnosed with T-cell acute ...
... to infectious diseases, researchers report , TUESDAY, May 11 ... malaria and blood poisoning account for more than two-thirds ... 5 years of age worldwide, a new report shows. ... birth complications, lack of oxygen during birth and congenital ...
... ... called on President Obama to investigate BBC News reports that detainees being held by ... are allegedly being subjected to prolonged isolation, temperature manipulation, and sleep deprivation. , ... Cambridge, MA (Vocus) -- ...
... lead to future treatments, researchers say , TUESDAY, May ... that are linked to Alzheimer,s disease and could become ... Genetic variants appear to play an important part in ... with the disease increases a person,s risk. It is ...
Cached Medicine News:Health News:New Menopause Supplement – Estrofil from BIOTX Limited – Offers All-Natural Relief from Menopausal Symptoms and Money-Back Guarantee 2Health News:New Menopause Supplement – Estrofil from BIOTX Limited – Offers All-Natural Relief from Menopausal Symptoms and Money-Back Guarantee 3Health News:Singapore's Gynaecologists Break New Grounds 2Health News:Singapore's Gynaecologists Break New Grounds 3Health News:Singapore's Gynaecologists Break New Grounds 4Health News:Genetic pattern that predicts leukemia relapse discovered 2Health News:Almost Half of Deaths in Kids Under 5 Occur in 5 Countries 2Health News:President Obama Must Investigate Reports of Detainee Abuse at Bagram Air Base 2Health News:New Alzheimer's Risk Genes Identified 2Health News:New Alzheimer's Risk Genes Identified 3
Total T3 EIA Thyroid Function 025-BC-1005...
... anti-TG test kit is a solid phase ... It is designed for the quantitative measurement ... in serum or plasma. The microplate is ... controls and patient samples are pipetted into ...
Free Estriol (E3) RIA Reproductive Hormones 024-IDC-2000...
... 17a Hydroxyprogesterone (17aOHP) is produced by ... Even,though 17aOHP has relatively little progestational ... interest because it is the,immediate precursor ... produced by 21-hydroxylation of 17aOHP,measurement of ...
Medicine Products: